Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study

Emi Sato, Naoko Obonai, Mayuko Iwata, Shiori Katayama, Hiroki Shimizu, Kotaro Ito, Shinichi Imafuku

Open source

DOI
10.1016/j.jdin.2026.09.008
Published
2026-12
Container
JAAD International
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jdin.2026.09.008,
  title = {Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study},
  author = {Emi Sato and Naoko Obonai and Mayuko Iwata and Shiori Katayama and Hiroki Shimizu and Kotaro Ito and Shinichi Imafuku},
  year = {2026},
  journal = {JAAD International},
  doi = {10.1016/j.jdin.2026.09.008},
  url = {https://doi.org/10.1016/j.jdin.2026.09.008}
}

RIS

TY  - JOUR
TI  - Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study
AU  - Emi Sato
AU  - Naoko Obonai
AU  - Mayuko Iwata
AU  - Shiori Katayama
AU  - Hiroki Shimizu
AU  - Kotaro Ito
AU  - Shinichi Imafuku
PY  - 2026
JO  - JAAD International
DO  - 10.1016/j.jdin.2026.09.008
UR  - https://doi.org/10.1016/j.jdin.2026.09.008
ER  - 

APA

Sato, E., Obonai, N., Iwata, M., Katayama, S., Shimizu, H., Ito, K., & Imafuku, S. (2026). Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study. JAAD International. https://doi.org/10.1016/j.jdin.2026.09.008

Source records